Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE Trial: First trimester progesterone therapy in unexplained recurrent miscarriage
2009-011208-42Phase 3Completed
- Sponsor
- Imperial College London
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Progesterone (Utrogestan) arm with Placebo arm (2 arms). Primary endpoint: Primary outcome: live birth beyond 24 weeks. Started May 2009; status: completed.
02
Drugs
progesterone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2009-011208-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011208-42.